We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

There is actually a wide variety of Swiss Army Knives of all shapes and sizes, despite it seeming like there's just one kind.

Free lunches, pizza, medical manuals, journal subscriptions, pens, reflex hammers ... tags with a drug company logo purely for decoration. Contrary to how physicians act, patients when surveyed ...

Meet Sterimove, the innovative mobile robot designed for Grade A/B/C/D cleanrooms, optimizing pharmaceutical production while ...

Piper Sandler analyst Allison Bratzel maintained a Buy rating on Ultragenyx Pharmaceutical (RARE – Research Report) today and set a price target of $115.00. The company’s shares closed last ...

Armata Pharmaceuticals Logo (PRNewsfoto/Armata Pharmaceuticals, Inc.) Proceeds from the new financing transaction will be used to advance the Company's lead therapeutic phage candidates, ...

The "Needle Free Drug Delivery Devices Market Industry Trends and Forecasts to 2035 -- Distribution by Type of Device, Route ...

Blog posts represent the views of CFR fellows and staff and not those of CFR, which takes no institutional positions. Most of the major U.S. pharmaceutical companies (AbbVie, Amgen, Bristol Myers ...

Jefferies initiated coverage of ANI Pharmaceuticals (ANIP) with a Buy rating and $80 price target The firm expects continued momentum for the shares, driven primarily by Cortrophin Gel and generics.

With official shortages ended, but the first generics gearing up for launch, companies are looking for the next generation of ...

Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...